Researcher profile · Semantic Scholar

E. Rathbone

h-index: 10
Works: 22
Citations: 683

Most-cited papers

Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.
R. Coleman, D. Cameron, D. Dodwell, R. Bell +11 more
2014The Lancet Oncology296 citations
Semantic Scholar
Management of cancer treatment-induced bone loss
R. Coleman, E. Rathbone, Janet E. Brown
2013Nature Reviews Rheumatology96 citations
Semantic Scholar
CCR6+ Th cells in the cerebrospinal fluid of persons with multiple sclerosis are dominated by pathogenic non-classic Th1 cells and GM-CSF-only-secreting Th cells
S. Restorick, L. Durant, S. Kalra, G. Hassan-smith +3 more
2017Brain, behavior, and immunity70 citations Open access
Semantic Scholar
Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04).
E. Rathbone, Janet E. Brown, H. Marshall, M. Collinson +10 more
2013Journal of Clinical Oncology51 citations Open access
Semantic Scholar
Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis
E. Rathbone, L. Durant, J. Kinsella, A. Parker +3 more
2018Journal of Neurology Neurosurgery & Psychiatry42 citations Open access
Semantic Scholar
Edinburgh Research Explorer Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial
Janet Brown, E. Rathbone, S. Hinsley, Walter M. Gregory +12 more
40 citations
Semantic Scholar
A Human In Vitro T Cell Exhaustion Model for Assessing Immuno-Oncology Therapies
Lynne S. Dunsford, Rosie H. Thoirs, E. Rathbone, A. Patakas
202021 citations
Semantic Scholar
Abstract S6-4: Vitamin D, but not bone turnover markers, predict relapse in women with early breast cancer: an AZURE translational study.
R. Coleman, E. Rathbone, H. Marshall, C. Wilson +5 more
201218 citations
Semantic Scholar
First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study
Laura Moliner, N. Zellweger, S. Schmid, M. Bertschinger +31 more
2024JTO Clinical and Research Reports15 citations Open access
Semantic Scholar
CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial
R. Coleman, Janet E. Brown, E. Rathbone, L. Flanagan +8 more
2020Trials13 citations Open access
Semantic Scholar
A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results
M. Winter, R. Coleman, J. Kendall, C. Palmieri +12 more
2022Journal of Bone Oncology11 citations Open access
Semantic Scholar
Prolonged bone health benefits for breast cancer patients following adjuvant bisphosphonate therapy: the BoHFAB study.
Janet Brown, M. Paggiosi, E. Rathbone, Walter M. Gregory +7 more
2024Journal of Bone and Mineral Research6 citations Open access
Semantic Scholar
Early experience of maintenance durvalumab post chemoradiation (CRT) in stage III non-small cell lung cancer (NSCLC) across West Yorkshire network: from Expanded Access Programme (EAP) to routine clinical use
P. Jain, P. Murray, K. Clarke, K. Franks +6 more
20206 citations
Semantic Scholar
Adjuvant bisphosphonates in early breast cancer
E. Rathbone
20181 citations
Semantic Scholar
204 REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in advanced non-small cell lung cancer (NSCLC) utilising a novel multi-arm design
E. Ghorani, M. Quartagno, F. Blackhall, M. O'Brien +33 more
2024Lung Cancer0 citations
Semantic Scholar
BoHFAB. The impact of adjuvant zoledronate therapy on bone health in postmenopausal patients with early breast cancer
Janet E. Brown, Margaret A. Paggiosi, E. Rathbone, D. Dodwell +4 more
2024Journal of Bone Oncology0 citations Open access
Semantic Scholar
Abstract PS14-02: A randomised phase IB/IIA study of CApecitabine plus Radium-223 in breast cancer patients with BONe metastases (CARBON) - Safety and preliminary efficacy findings
M. Winter, J. Kendall, Sarah R. Brown, E. Rathbone +8 more
2021Poster Session Abstracts0 citations
Semantic Scholar
MolPharm/CABS 2018
Gabriel M. Pagnotti, R. Pattyn, Laura E. Wright, Sutha Johns +23 more
2018Journal of Bone Oncology0 citations Open access
Semantic Scholar
Investigation of the adaptive immune response in multiple sclerosis
E. Rathbone
20180 citations
Semantic Scholar
CCR6+ Th cells in the cerebrospinal fluid of persons with multiple sclerosis are dominated by pathogenic non-classic Th1 cells and GM-CSF-only-secreting Th cells
L. Durant, S. Kalra, G. Hassan-Smith, E. Rathbone +2 more
20170 citations
Semantic Scholar
Project One: Inhibitory and immunomodulatory properties of human choroid plexus epithelial cells and Project Two: Characterisation of human mesenchymal stromal cells from different sources and the effects of therapeutic ultrasound
E. Rathbone
20140 citations
Semantic Scholar
Mandela's Prosecutor
E. Rathbone
20130 citations
Semantic Scholar

C. Wilson

×3

H. Marshall×3

S. Curnow×3

Walter M. Gregory×3

David Cameron×3

Robert Coleman×3

R. Coleman×3

J. Kendall×3